Publication | Open Access
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer
53
Citations
19
References
2011
Year
Immunotherapy regimen was tolerated. Survival results are encouraging.
| Year | Citations | |
|---|---|---|
Page 1
Page 1